{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T06:50:40Z","timestamp":1688626240180},"reference-count":34,"publisher":"Impact Journals, LLC","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,6,28]]},"DOI":"10.18632\/oncotarget.9645","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T23:53:57Z","timestamp":1464306837000},"page":"39231-39240","source":"Crossref","is-referenced-by-count":5,"title":["The associations between serum biomarkers and stenosis of the coronary arteries"],"prefix":"10.18632","volume":"7","author":[{"given":"Lei","family":"Feng","sequence":"first","affiliation":[{"name":"Department of Laboratory, People's Hospital of Yuxi City, Yuxi City, Yunnan, P.R. China"},{"name":"Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Baiyun District, Guangzhou, Guangdong, P.R. China"},{"name":"Department of Laboratory, The Sixth Affiliated Hospital of Kunming Medical University, Yuxi City, Yunnan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyan","family":"Nian","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, People's Hospital of Yuxi City, Yuxi City, Yunnan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Laboratory, The Sixth Affiliated Hospital of Kunming Medical University, Yuxi City, Yunnan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Laboratory, People's Hospital of Yuxi City, Yuxi City, Yunnan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingfeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Laboratory, People's Hospital of Yuxi City, Yuxi City, Yunnan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Laboratory, People's Hospital of Yuxi City, Yuxi City, Yunnan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Baiyun District, Guangzhou, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,5,26]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1161\/CIRCULATIONAHA.113.004046","article-title":"The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study","volume":"129","author":"Naghavi","year":"2014","journal-title":"Circulation"},{"key":"2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2014.160","article-title":"Coronary microvascular dysfunction: mechanisms and functional assessment","volume":"12","author":"Rimoldi","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: a perspective for the 1990s","volume":"362","author":"Ross","year":"1993","journal-title":"Nature"},{"key":"4","unstructured":"World Health Organization. Global Burden of Disease 2004. http:\/\/www.who.int\/healthinfo\/global_burden_disease\/2004_report_update\/en\/."},{"key":"5","unstructured":"World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. http:\/\/www.who.int\/healthinfo\/global_burden_disease\/global_health_risks\/en\/."},{"key":"6","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","article-title":"Immune effector mechanisms implicated in atherosclerosis: from mice to humans","volume":"38","author":"Hansson","year":"2013","journal-title":"Immunity"},{"key":"7","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.290.14.1906","article-title":"Obstructive sleep apnea: implications for cardiac and vascular disease","volume":"290","author":"Somers","year":"2003","journal-title":"JAMA"},{"key":"8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/heartjnl-2014-306068","article-title":"The validation of cardiovascular risk scores for patients with type 2 diabetes mellitus","volume":"101","author":"Peelen","year":"2015","journal-title":"Heart"},{"key":"9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Lisheng","year":"2004","journal-title":"Lancet"},{"key":"10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-141-6-200409210-00007","article-title":"Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus","volume":"141","author":"Golden","year":"2004","journal-title":"Ann Intern Med"},{"key":"11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Holman","year":"2000","journal-title":"BMJ"},{"key":"12","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1742-1241.2012.02956.x","article-title":"New directions in cardiovascular risk assessment: the role of secondary risk stratification markers","volume":"66","author":"Wierzbicki","year":"2012","journal-title":"Int J Clin Pract"},{"key":"13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3810\/pgm.2010.03.2119","article-title":"Cardiorenal interaction: appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease","volume":"122","author":"Verrill","year":"2010","journal-title":"Postgrad Med"},{"key":"14","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jacc.2011.05.028","article-title":"Homocysteine and reclassification of card24iovascular disease risk","volume":"58","author":"Afonso","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"15","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Johnson","year":"2008","journal-title":"N Engl J Med"},{"key":"16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10741-011-9242-6","article-title":"Cystatin C: a step forward in assessing kidney function and cardiovascular risk","volume":"17","author":"Harjola","year":"2012","journal-title":"Heart Fail Rev"},{"key":"17","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1097\/HJH.0b013e32833ec377","article-title":"The progressive pathway of microalbuminuria: from early marker of renal damage to strong cardiovascular risk predictor","volume":"28","author":"Mul\u00e8","year":"2010","journal-title":"J Hypertens"},{"key":"18","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.ijcard.2012.03.157","article-title":"Association between gamma-glutamyltransferase and coronary artery calcification","volume":"167","author":"Eryonucu","year":"2013","journal-title":"Int J Cardiol"},{"key":"19","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.amjcard.2014.08.043","article-title":"Effect of low serum total bilirubin levels (\u22640. 32 mg\/dl) on risk of coronary artery disease in patients with metabolic syndrome","volume":"114","author":"Moon","year":"2014","journal-title":"Am J Cardiol"},{"key":"20","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Shero","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jacc.2014.06.1159","article-title":"2013 ACC\/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol","volume":"64","author":"Grundy","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"22","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/CIRCULATIONAHA.113.000962","article-title":"Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges","volume":"128","author":"Webb","year":"2013","journal-title":"Circulation"},{"key":"23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/0003319711426868","article-title":"High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome","volume":"63","author":"Kaya","year":"2012","journal-title":"Angiology"},{"key":"24","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0002-9149(01)01566-1","article-title":"Sex differences in uric acid and risk factors for coronary artery disease","volume":"87","author":"Johnson","year":"2001","journal-title":"Am J Cardiol"},{"key":"25","first-page":"e76","article-title":"Serum Uric Acid and Coronary Heart Disease in 9,458 Incident Cases and 155,084 Controls: Prospective Study and Meta-Analysis PLoS","volume":"2","author":"Danesh","year":"2005","journal-title":"Med"},{"key":"26","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/oby.2011.136","article-title":"Serum \u03b3-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease","volume":"20","author":"Do\u011fan","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"27","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/hep.23789","article-title":"Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data","volume":"52","author":"Sattar","year":"2010","journal-title":"Hepatology"},{"key":"28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00380-011-0228-z","article-title":"Characterization of the effect of serum bilirubin concentrations on coronary endothelial functionmeasurement of high-sensitivity C-reactive protein and high-density lipoprotein cholesterol","volume":"28","author":"Nakazaki","year":"2013","journal-title":"Heart Vessels"},{"key":"29","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.amjcard.2013.08.018","article-title":"Relation of conjugated bilirubin concentrations to the presence of coronary artery calcium","volume":"112","author":"Byrne","year":"2013","journal-title":"Am J Cardiol"},{"key":"30","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/01.CIR.86.3.1026","article-title":"Health policy on blood cholesterol. Time to change directions","volume":"86","author":"Newman","year":"1992","journal-title":"Circulation"},{"key":"31","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/01.CIR.89.5.2462","article-title":"A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association","volume":"89","author":"Wissler","year":"1994","journal-title":"Circulation"},{"key":"32","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1161\/01.CIR.87.6.1781","article-title":"Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease","volume":"87","author":"Albers","year":"1993","journal-title":"Circulation"},{"key":"33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/jech-2015-206357","article-title":"Screening for suspected coronary heart disease in patients, using integrated serum biochemical indices","volume":"70","author":"Li","year":"2016","journal-title":"J Epidemiol Community Health"},{"key":"34","first-page":"e354","article-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","volume":"126","author":"Krumholz","year":"2012","journal-title":"Circulation"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T18:26:46Z","timestamp":1656613606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,26]]},"references-count":34,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2016,6,28]]}},"alternative-id":["9645","27250030"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9645","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,26]]}}}